DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Malcolm Johnson :

Malcolm Johnson

University of Newcastle-upon-Tyne

Paper: Bronchodilators:Past,Present and Future.

Download Presentation PDF

Dr. Malcolm Johnson graduated in pharmacy, and obtained his PhD in pharmacology from the University of Newcastle-upon-Tyne, UK. He was a post-doctoral research associate at Stanford University, California and a lecturer at Georgetown University Medical Centre, Washington D.C. before joining ICI Pharmaceuticals as a senior scientist in 1975. He was appointed Head of Cardiovascular and Respiratory Pharmacology at Glaxo Group Research in 1985, and subsequently Director of Respiratory Science, Glaxo Wellcome. From 2000,he was Global Director of Respiratory Science, GlaxoSmithKline and Visiting Professor, NHLI, Imperial College, London. He is now a Respiratory Science Consultant to GSK. He is an active member of the American Thoracic Society and European Respiratory Society. His research interests are mechanisms of respiratory diseases, receptor pharmacology and inflammation. He is a reviewer for several international medical/scientific journals and has published over 200 research articles.

Photos of Malcolm Johnson

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk